Identifying "at-risk" patients for sub-optimal beta-lactam exposure in critically ill patients with severe infections

被引：16
|
作者：
Abdul-Aziz, Mohd H. [1 ,2 ]
Lipman, Jeffrey [1 ,3 ]
Roberts, Jason A. [1 ,3 ,4 ,5 ]
机构：
[1] Univ Queensland, Ctr Clin Res UQCCR, Fac Med, Royal Brisbane & Womens Hosp, Bldg 71-918, Brisbane, Qld 4029, Australia
[2] Int Islamic Univ Malaysia, Sch Pharm, Kuantan, Malaysia
[3] Royal Brisbane & Womens Hosp, Dept Intens Care Med, Brisbane, Qld, Australia
[4] Univ Queensland, Sch Pharm, Ctr Translat Antiinfect Pharmacodynam, Brisbane, Qld, Australia
[5] Royal Brisbane & Womens Hosp, Dept Pharm, Brisbane, Qld, Australia
来源：
CRITICAL CARE | 2017年 / 21卷
基金：
英国医学研究理事会;
关键词：
Augmented renal clearance; Critically ill; Meropenem; Pharmacokinetic; Pharmacodynamic; Risk assessment tool; MEROPENEM;
D O I：
10.1186/s13054-017-1871-2
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Identifying “at-risk” patients for sub-optimal beta-lactam exposure in critically ill patients with severe infections
    Mohd H. Abdul-Aziz
    Jeffrey Lipman
    Jason A. Roberts
    Critical Care, 21
  • [2] Continuous beta-lactam infusion in critically ill patients: the clinical evidence
    Abdul-Aziz, Mohd H.
    Dulhunty, Joel M.
    Bellomo, Rinaldo
    Lipman, Jeffrey
    Roberts, Jason A.
    ANNALS OF INTENSIVE CARE, 2012, 2
  • [3] Continuous beta-lactam infusion in critically ill patients: the clinical evidence
    Mohd H Abdul-Aziz
    Joel M Dulhunty
    Rinaldo Bellomo
    Jeffrey Lipman
    Jason A Roberts
    Annals of Intensive Care, 2
  • [4] Beta-lactam antibiotics in continuous infusion in critically ill patients
    Axel Jeurissen
    Robert Rutsaert
    Critical Care, 14
  • [5] Beta-lactam antibiotics in continuous infusion in critically ill patients
    Jeurissen, Axel
    Rutsaert, Robert
    CRITICAL CARE, 2010, 14 (05):
  • [6] Pharmacokinetics and pharmacodynamics of beta-lactam antibiotics in critically ill patients
    Sulaiman, Helmi
    Roberts, Jason A.
    Abdul-Aziz, Mohd H.
    FARMACIA HOSPITALARIA, 2022, 46 (03) : 182 - 190
  • [7] The higher the better? Defining the optimal beta-lactam target for critically ill patients to reach infection resolution and improve outcome
    Scharf, Christina
    Liebchen, Uwe
    Paal, Michael
    Taubert, Max
    Vogeser, Michael
    Irlbeck, Michael
    Zoller, Michael
    Schroeder, Ines
    JOURNAL OF INTENSIVE CARE, 2020, 8 (01)
  • [8] Continuous infusion of beta-lactam antibiotics in critically ill patients with sepsis: implementation considerations
    Barton, Greg
    Rickard, Claire M.
    Roberts, Jason A.
    INTENSIVE CARE MEDICINE, 2024, 50 (12) : 2150 - 2153
  • [9] Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis
    Abdul-Aziz, Mohd H.
    Sulaiman, Helmi
    Mat-Nor, Mohd-Basri
    Rai, Vineya
    Wong, Kang K.
    Hasan, Mohd S.
    Abd Rahman, Azrin N.
    Jamal, Janattul A.
    Wallis, Steven C.
    Lipman, Jeffrey
    Staatz, Christine E.
    Roberts, Jason A.
    INTENSIVE CARE MEDICINE, 2016, 42 (10) : 1535 - 1545
  • [10] A protocol for a multicentre randomised controlled trial of continuous beta-lactam infusion compared with intermittent beta-lactam dosing in critically ill patients with severe sepsis: the BLING II study
    Dulhunty, Joel M.
    Roberts, Jason A.
    Davis, Joshua S.
    Webb, Steven A. R.
    Bellomo, Rinaldo
    Gomersall, Charles
    Shirwadkar, Charudatt
    Eastwood, Glenn M.
    Myburgh, John
    Paterson, David L.
    Starr, Therese
    Udy, Andrew A.
    Paul, Sanjoy K.
    Lipman, Jeffrey
    CRITICAL CARE AND RESUSCITATION, 2013, 15 (03) : 179 - 185
12345